Clinical Trials Sponsored by Shin Nippon Biomedical Laboratories, Ltd.

Total 4 results

Shin Nippon Biomedical Laboratories, Ltd.

Completed

Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

Chemotherapy-Induced Nausea and Vomiting

United States
National University Hospital, Singapore
Otsuka Pharmaceutical Co., Ltd.; Shin Nippon Biomedical Laboratories, Ltd.

Terminated

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

Nasopharyngeal Carcinoma

Singapore
iStat Biomedical CO., Ltd.
Mackay Memorial Hospital; Chang Gung Memorial Hospital; Li Shin Hospital

Unknown

DNA Methylation Biomarkers for Cervical Cancer Screening

Cervical Cancer | Cervical Intraepithelial Neoplasia

Taiwan
KARE Biosciences
Biomedical Advanced Research and Development Authority; BioLink Life Sciences... and other collaborators

Recruiting

Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

COVID-19 Pneumonia | COVID-19 Respiratory Infection

India

3

Subscribe